Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination

Clinical trial NCT01153906 · COMPLETED

Trial details

NCT number: NCT01153906
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Infections, Papillomavirus

Start date: 2010-10-01
Primary completion: 2013-09-01
Enrollment: 1516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.